NEW YORK, April 4 (Reuters) – Valeant Pharmaceuticals International Inc will cut its sales force for Addyi, a treatment aimed at female sexual dysfunction, as well as some employees who sell…
The post UPDATE 1-Valeant to cut Addyi, dermatology sales forces -memo appeared first on NASDAQ.